echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Blood System > The latest guidelines ACR & EULAR jointly issued new classification criteria for granulomatosis with polyangiitis, microscopic polyangiitis and eosinophilic granulomatosis with vasculitis

    The latest guidelines ACR & EULAR jointly issued new classification criteria for granulomatosis with polyangiitis, microscopic polyangiitis and eosinophilic granulomatosis with vasculitis

    • Last Update: 2022-05-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The 2022 vasculitis classification criteria jointly issued by ACR and EULAR have been successively published in the authoritative journals in the field of rheumatology Arthritis & Rheumatology and Annals of Rheumatic Diseases


     

    1

    eosinophilic granulomatosis with polyangiitis

     

    107 cases of EGPA and 450 controls were included in the development of the EGPA classification criteria


     

    DOI: 10.


     

    2

    granulomatosis with polyangiitis

     

    Granulomatosis with polyangiitis (GPA) classification criteria included 578 GPA cases and 652 comparators


     

     

     

    • DOI:10.


     

     

    3


    Microscopic polyangiitis

    149 patients with MPA and 408 controls were included in the development of the classification criteria for microscopic polyangiitis (MPA)


     

     

    The standard has a sensitivity of 91% and a specificity of 94%


     

    • DOI: 10.


     

    The 2022 vasculitis classification criteria jointly issued by ACR and EULAR have been successively published in the authoritative journals in the field of rheumatology Arthritis & Rheumatology and Annals of Rheumatic Diseases


    Vascular Arthritis & Rheumatology Annals of Rheumatic DiseasesDiagnosis

     

    1

    eosinophilic granulomatosis with polyangiitis

     

    107 cases of EGPA and 450 controls were included in the development of the EGPA classification criteria


     

    DOI: 10.


    DOI: 10.


    2

    granulomatosis with polyangiitis

     

    Granulomatosis with polyangiitis (GPA) classification criteria included 578 GPA cases and 652 comparators


     

     

     

    • DOI:10.


  • DOI:10.


  • DOI:10.
    1002/art.
    41986

    DOI:10.
    1002/art.
    41986

     

     

    3



    Microscopic polyangiitis

    149 patients with MPA and 408 controls were included in the development of the classification criteria for microscopic polyangiitis (MPA)
    .
    The validation set consisted of another 142 MPAs and 414 controls
    .
    From the 91 candidate items, regression analysis identified 10 MPA items and finally 6 items
    .

     

     

     

    The standard has a sensitivity of 91% and a specificity of 94%
    .

     

    • DOI: 10.
      1136/annrheumdis-2021-221796

  • DOI: 10.
    1136/annrheumdis-2021-221796

  • DOI: 10.
    1136/annrheumdis-2021-221796

    DOI: 10.
    1136/annrheumdis-2021-221796

     



    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.